ME - 23andMe Holding Co.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
307,671
299,489
271,893
243,920
305,463
Cost of revenue
166,100
164,993
138,948
126,914
168,031
Gross profit
141,571
134,496
132,945
117,006
137,432
Operating expenses
Research development
212,201
222,596
189,377
159,856
181,276
Selling general and administrative
235,980
235,911
197,721
142,346
169,911
Total operating expenses
465,762
458,507
387,098
302,202
351,187
Operating income or loss
-324,191
-324,011
-254,153
-185,196
-213,755
Total other income/expenses net
-389
-93
32,906
1,322
-43,352
Income before tax
-319,209
-314,428
-220,970
-183,619
-250,863
Income tax expense
-2,107
-2,772
-3,480
0
0
Income from continuing operations
-317,102
-311,656
-217,490
-183,619
-250,863
Net income
-317,102
-311,656
-217,490
-183,619
-250,863
Net income available to common shareholders
-317,102
-311,656
-217,490
-183,619
-250,863
Basic EPS
-
-
-0.60
-0.45
-0.62
Diluted EPS
-
-
-0.60
-0.45
-0.62
Basic average shares
-
-
361,528
406,415
406,415
Diluted average shares
-
-
361,528
406,415
406,415
EBITDA
-
-287,513
-228,005
-164,950
-190,466